Universidade Federal do Acre, Centro Multidisciplinar, Cruzeiro do Sul, AC, Brazil.
Instituto Lauro de Souza Lima, Bauru/SP, Laboratório de Imunologia, Bauru, SP, Brazil.
Braz J Infect Dis. 2020 Jul-Aug;24(4):296-303. doi: 10.1016/j.bjid.2020.05.009. Epub 2020 Jun 24.
The frequencies of the Human leukocyte antigen (HLA) alleles in the Puyanawa indigenous reserve population and their association with the NDO-LID and ELISA PGL-1 rapid serological test was assessed. This was a cross-sectional study with an epidemiological clinical design conducted in two indigenous communities in the state of Acre, Brazil. Blood was collected in a tube with EDTA to identify HLA alleles and perform serological tests. DNA was obtained using the salting out procedure. The LabType™ technique (One-Lambda-USA) was used for HLA class I (loci A*, B* and C*) and II (loci DRB1*, DQA1* and DQB1*) typing. Allele frequency was obtained by direct count, and the chi-square test was used to assess the association with the NDO-LID and PGL-1 tests. The most frequent alleles in the two communities were: HLA-A02:01, HLA-B40:02, HLA-DRB116:02, HLA-DQA105:05 and HLA-DQB103:01. The allele HLA-C04:01 was the most common in the Barão community, and the allele HLA-C07:01 in Ipiranga. Among individuals who presented seropositivity to the NDO-LID test, the association with alleles HLA-A02 (43.18% vs 24.8%, p=0.03, OR=2.35) and HLA-B53 (6.83% vs 0.0%, p=0.03, OR=8.95) was observed in the Barão community. HLA-B15 was associated with non-seroconversion to the NDO-LID test in Ipiranga. In both communities, HLA-B40 and HLA-C03 were associated with positive serological response to ELISA PGL-1. The HLA class I and II alleles most frequently found in this study have already been described among Terena indigenous groups, and HLA class I contributes to seroconversion to NDO-LID and PGL-1 tests in inhabitants of the Barão and Ipiranga communities.
评估了普亚纳瓦原住民保护区人群中的人类白细胞抗原 (HLA) 等位基因频率及其与 NDO-LID 和 ELISA PGL-1 快速血清学检测的关联。这是一项在巴西阿克里州的两个原住民社区进行的具有流行病学临床设计的横断面研究。采集含 EDTA 的试管中的血液以鉴定 HLA 等位基因并进行血清学检测。使用盐析法获得 DNA。使用 LabType™技术(One-Lambda-USA)对 HLA Ⅰ类(A*、B和 C)和Ⅱ类(DRB1*、DQA1和 DQB1)进行基因分型。通过直接计数获得等位基因频率,并使用卡方检验评估与 NDO-LID 和 PGL-1 检测的关联。在这两个社区中最常见的等位基因是:HLA-A02:01、HLA-B40:02、HLA-DRB116:02、HLA-DQA105:05 和 HLA-DQB103:01。在巴朗社区中,最常见的等位基因是 HLA-C04:01,而在伊皮兰加社区中,最常见的等位基因是 HLA-C07:01。在 NDO-LID 检测呈血清阳性的个体中,在巴朗社区中观察到与 HLA-A02(43.18%对 24.8%,p=0.03,OR=2.35)和 HLA-B53(6.83%对 0.0%,p=0.03,OR=8.95)等位基因的关联。在伊皮兰加,HLA-B15 与 NDO-LID 检测的非血清转化有关。在这两个社区中,HLA-B40 和 HLA-C03 与 ELISA PGL-1 的阳性血清学反应有关。在这项研究中最常发现的 HLA Ⅰ类和Ⅱ类等位基因已经在特雷诺纳原住民群体中描述过,HLA Ⅰ类有助于巴朗和伊皮兰加社区居民对 NDO-LID 和 PGL-1 检测的血清转化。